Data from subjects receiving intrathecal laronidase for cervical spinal stenosis due to mucopolysaccharidosis type I-Reference-Cited by-同舟云学术

Data from subjects receiving intrathecal laronidase for cervical spinal stenosis due to mucopolysaccharidosis type I

Published:2015-12 Issue: Volume:5 Page:71-76
ISSN:2352-3409
Container-title:Data in Brief
language:en
Short-container-title:Data in Brief

Author:

Dickson P.I.,Kaitila I.,Harmatz P.,Mlikotic A.,Chen A.H.,Victoroff A.,Passage M.B.,Madden J.,Le S.Q.,Naylor D.E.

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference5 articles.

1. Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis I;Dickson;Mol. Genet. Metab.,2015

2. Abnormal somatosensory evoked potentials indicate compressive cervical myelopathy in mucopolysaccharidoses;Boor;Neuropediatrics,2000

3. Laminectomy and posterior cervical plating for multilevel cervical spondylotic myelopathy and ossification of the posterior longitudinal ligament: effects on cervical alignment, spinal cord compression, and neurological outcome;Houten;Neurosurgery,2003

4. Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation;Matheus;Neuroradiology,2004

5. Diagnostic test for mucopolysaccharidosis. II. Rapid quantification of glycosaminoglycan in urine samples collected on a paper matrix;Whitley;Clin. Chem.,1989

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment for Lysosomal Storage Disorders;Current Pharmaceutical Design;2020-11-27

2. Targeted enzyme delivery systems in lysosomal disorders: an innovative form of therapy for mucopolysaccharidosis;Cellular and Molecular Life Sciences;2019-05-17

3. Lysosomal Leukodystrophies Lysosomal Storage Diseases Associated With White Matter Abnormalities;Journal of Child Neurology;2019-02-13

4. Phase I and II clinical trials for the mucopolysaccharidoses;Expert Opinion on Investigational Drugs;2017-10-31

5. Efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age. A systematic review and meta-analysis;Molecular Genetics and Metabolism;2017-06